Northwire Canada EditionThursday, October 15, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4% GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4%
Production / Operations

KDA GROUP DEPLOYS MEDHERIZE ACROSS COMMUNITY PHARMACIES: A MAJOR STEP FORWARD IN THE MANAGEMENT OF ORAL ANTICANCER THERAPIES

By The Northwire Desk — AI Analysis Dec 01, 2025 · 13:45 KDA · 0.265 KDA Group Inc.
KDA · Price

Executive Summary

  • KDA Group announced the expansion of its Medherize digital platform from hospital use to community pharmacies across Quebec, including Horizon Santé and Jean Coutu locations.
  • The rollout aligns with Quebec’s new provincial framework for oral anticancer medication (OAM) management, enabling pharmacists to access oncologists’ treatment plans and patient lab results in real time.
  • Executives highlighted the platform’s role in improving adherence, early adverse‑effect detection, and coordinated care among oncologists, pharmacists, and patients.

Key Details

  • Deployment Scope: Medherize now active at CHU de Québec, Hôpital du Saint‑Sacrement (≈200 monitored patients) plus community pharmacies under Horizon Santé (22 sites) and a Jean Coutu pharmacy in Quebec City.
  • Regulatory Alignment: Fully compliant with the Ministère de la Santé et des Services sociaux’ new OAM framework requiring pharmacist evaluation, counseling, adverse‑effect monitoring, and continuity of care.
  • Platform Capabilities:
  • Direct access for pharmacists to oncologists’ therapeutic plans.
  • Automatic retrieval of laboratory results (including ECGs) via Dossier Santé Québec (DSQ).
  • Real‑time patient‑reported adverse‑effect tracking and adherence gap alerts.
  • Integrated dispensing, renewal, and secure data sharing across care teams.
  • Future Rollout: Additional hospital centers and community pharmacies slated for deployment as early as January 2026.
  • Executive Comments:
  • Jérôme Lavoie (President, Groupe Horizon Santé) praised Medherize for enabling rigorous monitoring and timely intervention.
  • Pierre‑Olivier Sirois (Pharmacist‑Owner, Jean Coutu) called the tool “indispensable” for precision and safety in OAM follow‑up.
  • Marc Lemieux (CEO & Chairman, KDA Group) emphasized the platform’s role in completing the care continuum and enhancing patient health outcomes.

Notable Quotes

  • “Medherize is a true breakthrough for our pharmacies and our patients… It enables highly rigorous monitoring, allows us to anticipate adverse effects, and helps us intervene at exactly the right moment.” – Jérôme Lavoie, President, Groupe Horizon Santé
  • “The Medherize platform is the result of years of work… Seeing physicians, pharmacists, and patients united through a single platform brings our vision to life.” – Marc Lemieux, CEO & Chairman, KDA Group
Read the original news release →

More from KDA Group Inc.

Jun 18, 2026 · 13:15

Clinical validation of Medherize confirms value prop, but tiny revenue and depleted cash demand urgent capital raise.

Other May 29, 2026 · 18:00

KDA Group Settles Debt with Equity Amidst Share Price Collapse

Financings May 05, 2026 · 13:30

Governance Cleanup Amidst Valuation Trough

Regulatory Dec 24, 2025 · 11:00

UPDATE OF THE TRANSACTION ANNOUNCED ON NOVEMBER 25, 2025, FOR THE ACQUISITION OF THE MINORITY INTEREST IN THE SUBSIDIARY GROUPE TECHNOLOGIQUE KDA INC.

M&A / Property Dec 03, 2025 · 10:30

KDA GROUP ANNOUNCES PARTNERSHIP AGREEMENT WITH CHU DE QUEBEC-UNIVERSITE LAVAL FOR THE DEPLOYMENT OF MEDHERIZE

M&A / Property Nov 25, 2025 · 15:00

KDA GROUP ANNOUNCES AGREEMENT TO ACQUIRE MINORITY INTEREST IN ITS SUBSIDIARY GROUPE TECHNOLOGIQUE KDA INC.

M&A / Property